Moreover, we presented first evidence that the NGAL-R/NGAL complex enhances the survival of CLL cells by activating an SRC/STAT3/Mcl-1 signaling pathway [18]. The gene discussed is SLC22A17; the disease is B-cell chronic lymphocytic leukemia.